Carole Ho
CIK 1724605 · Chief Medical Officer · last filed 2026-06-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.56M
Companies
4
Total Filings
99
Lifetime Open-Market Net
-$13.21M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RPRX | Director | 13,103 | $59.18 | $775.4K | $0 | 2 | 2026-06-08 |
| DNLI | Chief Medical Officer | 242,391 | $23.85 | $5.78M | -$13.21M | 66 | 2025-08-14 |
| BEAM | Director | — | $26.02 | — | $0 | 5 | 2025-06-06 |
| NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Director | — | $1.54 | — | $0 | 5 | 2024-04-08 |
Recent Filings · Page 9 of 10
99 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-08-22 | DNLI | Mixed | +2,809 | -$52.7K | EDGAR |
| 2019-07-10 | DNLI | Mixed | −10,989 | -$320.6K | EDGAR |
| 2019-06-12 | DNLI | Mixed | −12,883 | -$304.3K | EDGAR |
| 2019-05-10 | DNLI | Mixed | −9,688 | -$358.7K | EDGAR |
| 2019-05-10 | DNLI | Mixed | −19,033 | -$844.6K | EDGAR |
| 2019-04-08 | DNLI | Sell (S) | −9,588 | -$252.7K | EDGAR |
| 2019-04-03 | DNLI | Mixed | −30,757 | -$904.4K | EDGAR |
| 2019-03-18 | DNLI | Mixed | −500 | -$22.4K | EDGAR |
| 2019-03-05 | DNLI | Mixed | — | -$295.6K | EDGAR |
| 2019-02-11 | DNLI | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.